Fourth Gen Birth Control More Dangerous Than Previous Three Combined.

There has been an ever-growing concern over the risk of blood clots related to Yaz and Yasmin birth control pills, due to their active ingredient drospirenone, known as the 4th generation progestin. The concern has grown to the point where the FDA has launched an investigation into claims that drospirenone can lead to an excessive risk of Yaz blood clots in women taking the pill. The drug drospirenone is a newer version of levonorgestrel, which was found in the typical birth control contraceptive until about eight years ago. The FDA found that the risk of blood clots and venous thromboembolism was excessively high when compared to older levonorgestrel-containing pills and recommended that the labels be updated. Both the FDA and its European counterparts note that the overall risk of a blood clot is still small.

Popular Birth Control Found to Have Dangerous Side Effects

Over the last three years, Yaz has turned into not just the most popular birth control method in the U.S. but the most profitable as well. Bayer has done a major marketing campaign in order to accomplish this, even making it a favorite of doctors around the country. But these rigorous marketing campaigns have been criticized because they are misleading and sometimes not even true. Every day more women are reporting Yaz side effects they have experienced as a result of their prescription of Yaz. Yaz uses drospireonone, a synthetically made from of progestin, as do several other contraceptive drugs. Drospireonone is effective in preventing pregnancy.

Bayer Facing Thousands of Individual Lawsuits over Contraceptive

Bayer currently faces about 7,000 Yaz lawsuits. Although the cases have been consolidated and centralized for pretrial proceedings as part of an MDL, or multidistrict litigation, each claim remains and individual lawsuit and each plaintiff must meet the burden of proof in establishing that their injuries were caused by the use of the birth control pill. If a Yaz settlement agreement is not reached in the litigation, each of the plaintiffs will have the opportunity to present their claim to a jury. Bayer agreed to stop that particular ad campaign and they agreed to conduct a new, $20 million "corrective" marketing campaign with new commercials and print advertisements that clarified that Yaz birth control pill does not treat mild acne or help keep your skin clear or cure the symptoms of PMS (premenstrual syndrome.

Yaz Blood Clots Can be Fatal

Yaz brand birth control has many benefits to women, including prevention of pregnancy and reduction of acne. However, the benefits come with an extreme risk to women taking them – the serious side effects to the popular drug include potentially fatal blood clot and pulmonary embolism.
Over a thousand Yaz lawsuits have been filed by women who are taking the medication due to the fact that Bayer Corporation, the producers of the drug, have neglected to warn the public about the serious and life-threatening side effects of Yaz birth control, defending themselves with the claim that the benefits of the product far outweigh the risks involved in taking it.
The active ingredient in Yaz is the synthetic hormone drospirenone, which suppresses ovulation but also causes an excess of potassium in the blood, also called hyperkalemia. This can lead to changes in the electrical pulses that the body sends, causing irregular heartbeat, which in turn can cause a Yaz blood clot.

Yaz linked to Gallbladder Disease

The serious and life-altering Yaz side effects have contributed to the growing number of Yaz lawsuits including: Blood clots, Cardiac Arrhythmias, Stroke, Heart attack, Gallbladder Disease, Pulmonary embolism, Deep Vein Thrombosis (DVT) and Sudden death. The most common serious Yaz birth control side effects is Yaz gallbladder disease. For many otherwise healthy young women who take Yaz and Yasmin, a diagnosis of gallbladder disease comes as a complete shock.


Side effects of Yaz, Yasmin and other birth control pills that use the progestin drospirenone could increase the risk of Yaz gallbladder disease by as much as 20% when compared to older oral contraceptives, according to a new study by Canadian researchers. Many of these otherwise completely healthy individuals have had to undergo emergency Yaz gallbladder removal. 

Yaz Blood Clot Risk Heightens

According to two new studies recently published in the online edition of the British Medical Journal, Yaz contains a new progestin drospirenone (DSRP) and carries up to triple the risk of blood clots (known as venous thromboembolism) over traditional pills containing the progestin levonorgestrel (LNG). Bayer was warned by the Food and Drug Administration (FDA), in the fall of 2008, that Bayer’s television advertisements were misleading and did not disclose the additional side effects of Yaz.

Bayer Reeks Benefits While Women Suffer

Thousands of women throughout the United States have filed a Yaz lawsuit or Yasmin lawsuit against Bayer, alleging that the drug maker failed to adequately research the risks associated with the medication or warn women that they may be exposed to an increased risk of serious and potentially fatal side effects when using the birth control pills. Lawsuits also allege that Bayer engaged in deceptive and misleading advertisements that were directed to consumers and the medical community. Still, the researchers described the overall risk as low, with rates for blood-clotting cases in U.S. study of 30.8 per 100,000 women years on drospirenone versus 12.5 in the control group.
Bayer said in a statement that the methodology used showed "significant flaws."